Creutzfeldt-Jakob disease historical perspective: Difference between revisions
Jump to navigation
Jump to search
YazanDaaboul (talk | contribs) No edit summary |
|||
| Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
Creutzfeldt Jakob disease was first | Creutzfeldt Jakob disease was first described in 1920-1921 by two German [[neurologist]]s, [[Hans Gerhard Creutzfeldt]] and [[Alfons Maria Jakob]]. | ||
==Historical Perspective== | ==Historical Perspective== | ||
* | *Creutzfeldt Jakob disease was first described in 1920-1921 by two German [[neurologist]]s, [[Hans Gerhard Creutzfeldt]] and [[Alfons Maria Jakob]]. | ||
*The term ''Creutzfeldt Jakob'' was first coined by Spielmeyer in 1922 in honor of Creutzfeldt and Jakob's report.<ref name="McKintosh-2003">{{Cite journal | last1 = McKintosh | first1 = E. | last2 = Tabrizi | first2 = SJ. | last3 = Collinge | first3 = J. | title = Prion diseases. | journal = J Neurovirol | volume = 9 | issue = 2 | pages = 183-93 | month = Apr | year = 2003 | doi = 10.1080/13550280390194082 | PMID = 12707849 }}</ref> | |||
* [[Stanley B. Prusiner]] was awarded the | * In 1997, [[Stanley B. Prusiner]] was awarded the Nobel Prize in physiology or medicine for his discovery of [[prion]]s. | ||
*In 2007, Laura Manuelidis, an American neuropathologist, and her colleagues described a [[virus]]-like particle without nucleic acid in less than 10% of the cells a scrapie-infected cell line and in a mouse cell line infected by a human Creutzfeldt Jakob disease agent.<ref name="Manuelidis2007">{{cite journal| author=Manuelidis L| coauthors=Yu ZX, Barquero N, Mullins B|date=February 6, 2007| title=Cells infected with scrapie and Creutzfeldt-Jakob disease agents produce intracellular 25-nm virus-like particles| journal=Proceedings of the National Academy of Science| volume=104| issue=6| pages=1975-1970| pmid=17267596|url=http://www.pnas.org/cgi/content/full/104/6/1965| accessdate=2007-09-24}}</ref> | |||
==References== | ==References== | ||
| Line 20: | Line 21: | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Transmissible spongiform encephalopathies]] | [[Category:Transmissible spongiform encephalopathies]] | ||
Revision as of 19:29, 17 March 2016
|
Creutzfeldt-Jakob disease Microchapters |
|
Differentiating Creutzfeldt-Jakob disease from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Creutzfeldt-Jakob disease historical perspective On the Web |
|
American Roentgen Ray Society Images of Creutzfeldt-Jakob disease historical perspective |
|
Creutzfeldt-Jakob disease historical perspective in the news |
|
Risk calculators and risk factors for Creutzfeldt-Jakob disease historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Creutzfeldt Jakob disease was first described in 1920-1921 by two German neurologists, Hans Gerhard Creutzfeldt and Alfons Maria Jakob.
Historical Perspective
- Creutzfeldt Jakob disease was first described in 1920-1921 by two German neurologists, Hans Gerhard Creutzfeldt and Alfons Maria Jakob.
- The term Creutzfeldt Jakob was first coined by Spielmeyer in 1922 in honor of Creutzfeldt and Jakob's report.[1]
- In 1997, Stanley B. Prusiner was awarded the Nobel Prize in physiology or medicine for his discovery of prions.
- In 2007, Laura Manuelidis, an American neuropathologist, and her colleagues described a virus-like particle without nucleic acid in less than 10% of the cells a scrapie-infected cell line and in a mouse cell line infected by a human Creutzfeldt Jakob disease agent.[2]
References
- ↑ McKintosh, E.; Tabrizi, SJ.; Collinge, J. (2003). "Prion diseases". J Neurovirol. 9 (2): 183–93. doi:10.1080/13550280390194082. PMID 12707849. Unknown parameter
|month=ignored (help) - ↑ Manuelidis L (February 6, 2007). "Cells infected with scrapie and Creutzfeldt-Jakob disease agents produce intracellular 25-nm virus-like particles". Proceedings of the National Academy of Science. 104 (6): 1975–1970. PMID 17267596. Retrieved 2007-09-24. Unknown parameter
|coauthors=ignored (help)